Early research involving 20 mg and 40 mg doses of retatrutide has shown occasional dose-dependent increases in pulse rate during initial treatment, which generally stabilise as the body adapts over time
For trial enrollment paths today, see how to get retatrutide in 2026
Implantable long-duration semaglutide devices
Put simply, dopamine relays signals across different areas of the brain, rewarding biologically advantageous behaviors like experiencing sensory pleasure or getting enough food, sex, or rest
Recent Developments: Initiated Phase 3 trials for maritide (caftaglutide), targeting both GLP-1 and GIP receptors
This should be accounted for in research designs that include oral glucose tolerance tests or mixed meal tolerance tests, as retatrutides pharmacodynamic effects will blunt the glycemic response independent of changes in fasting glucose or insulin sensitivity